Understanding Engagement in Diabetic Kidney Disease Studies
This study is looking at the experiences of people with diabetic kidney disease who are already participating in another clinical study that involves a specific medication. Researchers want to understand why people join these studies and why some might leave before the study is finished. The goal is to learn how to better support patients in future studies, especially those from under-represented groups. You can join if you are at least 18 years old, have diabetic kidney disease, and are currently in another clinical study with a medication intervention. The study will measure how many people decide to join a diabetic kidney disease study (at 3 months) and how many stay until the end (at 12 months). The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will watch and collect information without providing new treatments. It plans to include about 500 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track participants for up to 12 months to see if they complete their separate clinical trial.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who decide to enroll in a diabetic kidney disease clinical research3 months
- Rate of patients who remain in a diabetic kidney disease clinical trial to trial completion12 months